Literature DB >> 19946421

Expansion of CD8+CD57+ T Cells in an Immunocompetent Patient with Acute Toxoplasmosis.

R García-Muñoz1, P Rodríguez-Otero, A Galar, J Merino, J J Beunza, J A Páramo, R Lecumberri.   

Abstract

CD57+ T cells increase in several viral infections like cytomegalovirus, herpesvirus, parvovirus, HIV and hepatitis C virus and are associated with several clinical conditions related to immune dysfunction and ageing. We report for the first time an expansion of CD8+ CD57+ T cells in a young patient with an acute infection with Toxoplasma gondii. Our report supports the concept that CD8+ CD57+ T cells could be important in the control of chronic phase of intracellular microorganisms and that the high numbers of these cells may reflect the continuing survey of the immune system, searching for parasite proliferation in the tissues.

Entities:  

Year:  2009        PMID: 19946421      PMCID: PMC2778835          DOI: 10.1155/2009/173439

Source DB:  PubMed          Journal:  Adv Hematol


1. Introduction

Toxoplasma gondii, an obligate intracellular protozoan, can invade and replicate in almost any nucleated host cell, being cats and their pray the definitive hosts. Oocysts shed in cat feces can infect a wide range of animals including humans. Infection occurs by ingestion of parasite-cyst-contaminated food or water; cysts rupture in the host, and the released parasites actively enter host cells [1]. Certain individuals are at high risk for severe disease, especially congenitally infected fetuses and newborns and immunologically impaired individuals [2]. Infection in immunocompetent hosts is usually asymptomatic and self-limited, and it does not normally require therapy [2]. Individuals infected with Toxoplasma gondii require a powerful immune response to contain dissemination of the parasite, resulting in a strong and persistent T-helper-1 (Th1) response characterised by production of proinflammatory cytokines including IL-12, INF-γ, and TNF-α [3]. Human CD4+ and CD8+ T lymphocytes are cytotoxic to Toxoplasma gondii-infected cells [4]. However, the possible implication of CD8+CD57+ T cells in the control of acute infection and the tissues survey in the chronic phase has never been described. We report a patient with acute toxoplasmosis with increased levels of CD8+CD57+ T cells in peripheral blood.

2. Case Report

A 20-year-old man presented with a 3-week history of fatigue and cervical lymphadenophaty. Chest X-ray was normal, but reactive laterocervical and jugulodigastric lymphadenophaties were found in cervical ultrasound. At presentation, peripheral blood count revealed a white blood cell count (WBC) of 5.9 × 109/L with 58.9% lymphocytes (3.5 × 109/L) and absolute neutrophil count (ANC) of 29.7% (1.75 × 109/L), and blood smear demonstrated the presence of numerous stimulated lymphocytes with intracytoplasmatic granules. Screening for infectious disease was performed including HIV, Epstein-Barr virus, cytomegalovirus, and Toxoplasma gondii. All results were negative except for positive IgM and IgG enzyme-linked immunosorbent assay to Toxoplasma gondii; the weakly IgG avidity test (low avidity) confirmed recent acquired infection. Flow cytometry analysis revealed an increase in the number of CD8+ T cells with a high grade of activation (67% expressed HLA-DR) and replicative senescence (49% expressed CD57); see Figure 1. Normal levels of CD4+ T cells and B cells were also observed (Table 1). The patient is currently asymptomatic and without treatment, with few nontender and discrete cervical lymph nodes.
Figure 1

Increased number of CD8+ T cells with a high grade of activation (HLA-DR) and replicative senescence (CD57+).

Table 1

T cells, B cells, and NK cells counts by flow cytometry in whole peripheral blood.

% whole blood cells Cells/μLNormal range cells/μL
T cells543186933–2491
CD4+ T cells15885370–1468
CD8+ T cells382242183–799
NK cells6.739560–495
B cells211865–595

3. Discussion

CD57+ T lymphocytes are virtually absent at birth [5] and progressively increasing with age [6]. CD8+CD57+ T cells increases in chronic immune activation states and in infectious diseases like HIV [7], tuberculosis [8], and some virus, particularly cytomegalovirus [9, 10]. However, increased numbers of these cells in toxoplasmosis have never been reported before. Interestingly, INF-gamma production is directly correlated with CD8+CD28-CD57+ T cells and age [11]. More over, IFN-gamma is crucial in protective immunity against Toxoplasma gondii infection, and CD8+CD57+ T cells can proliferate and produce high amounts of INF-gamma and IL-5 [12]. Both cytokines are related with a protective role against Toxoplasma gondii infection [13]. Taken together, is possible that CD8+CD57+ T cells could prevent the reactivation of old intruders that cannot be cleared in the young age, in particular CMV [9] and Toxoplasma gondii infections. We suggest that CD8+CD57+ T prevent the reactivation of Toxoplasma gondii in a similar manner that CD8+CD57+ T cells can control CMV reactivation in elderly individuals.
  12 in total

1.  The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28(-)CD57(+) subpopulation.

Authors:  E Bandrés; J Merino; B Vázquez; S Inogés; C Moreno; M L Subirá; A Sánchez-Ibarrola
Journal:  Clin Immunol       Date:  2000-09       Impact factor: 3.969

Review 2.  Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii.

Authors:  Julio Aliberti
Journal:  Nat Rev Immunol       Date:  2005-02       Impact factor: 53.106

3.  Characterization of a cytotoxic CD57+ T cell subset from patients with pulmonary tuberculosis.

Authors:  I Sada-Ovalle; L Torre-Bouscoulet; R Valdez-Vázquez; S Martínez-Cairo; E Zenteno; R Lascurain
Journal:  Clin Immunol       Date:  2006-10-10       Impact factor: 3.969

Review 4.  Cytokine regulation of immunopathology in toxoplasmosis.

Authors:  Pamela J Gaddi; George S Yap
Journal:  Immunol Cell Biol       Date:  2007-01-16       Impact factor: 5.126

5.  High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals.

Authors:  Yannick Le Priol; Denis Puthier; Cédric Lécureuil; Christophe Combadière; Patrice Debré; Catherine Nguyen; Béhazine Combadière
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

6.  Longitudinal survey of lymphocyte subpopulations in the first year of life.

Authors:  E de Vries; S de Bruin-Versteeg; W M Comans-Bitter; R de Groot; W C Hop; G J Boerma; F K Lotgering; J J van Dongen
Journal:  Pediatr Res       Date:  2000-04       Impact factor: 3.756

Review 7.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

8.  Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells.

Authors:  J G Montoya; K E Lowe; C Clayberger; D Moody; D Do; J S Remington; S Talib; C S Subauste
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Role of persistent CMV infection in configuring T cell immunity in the elderly.

Authors:  Sonya Vasto; Giuseppina Colonna-Romano; Anis Larbi; Anders Wikby; Calogero Caruso; Graham Pawelec
Journal:  Immun Ageing       Date:  2007-03-21       Impact factor: 6.400

10.  Proliferation and interleukin 5 production by CD8hi CD57+ T cells.

Authors:  Lee K Chong; Rebecca J Aicheler; Sian Llewellyn-Lacey; Peter Tomasec; Paul Brennan; Eddie C Y Wang
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

View more
  3 in total

Review 1.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

Review 2.  Human CD8+ T Cells in Asthma: Possible Pathways and Roles for NK-Like Subtypes.

Authors:  Olga Lourenço; Ana Mafalda Fonseca; Luis Taborda-Barata
Journal:  Front Immunol       Date:  2016-12-23       Impact factor: 7.561

Review 3.  Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease.

Authors:  Carolyn M Nielsen; Matthew J White; Martin R Goodier; Eleanor M Riley
Journal:  Front Immunol       Date:  2013-12-09       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.